prikaz prve stranice dokumenta Present criteria for prophylactic ICD implantation: Insights from the EU-CERT-ICD (Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators in EUrope) project
Access restricted to students and staff of home institution
Scientific paper - Review paper
Present criteria for prophylactic ICD implantation: Insights from the EU-CERT-ICD (Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators in EUrope) project
Journal of electrocardiology, 19 (2019); 30415-10417. https://doi.org/10.1016/j.jelectrocard.2019.09.001
Zabel, Markus; Schlögl, Simon; Lubinski, Andrzej; Svendsen, Jesper Hastrup; Bauer, Axel; Arbelo, Elena; Brusich, Sandro; Conen, David; Cygankiewicz, Iwona; Dommasch, Michael; Flevari, Panagiota; Galuszka, Jan; Hansen, Jim; Hasenfuß, Gerd; Hatala, Robert; Huikuri, Heikki V.; Kenttä, Tuomas; Kucejko, Tomasz; Haarmann, Helge; Harden, Markus; Iovev, Svetoslav; Kääb, Stefan; Kaliska, Gabriela; Katsimardos, Andreas; Kasprzak, Jaroslaw D.; Qavoq, Dariusz; Lüthje, Lars; Malik, Marek; Novotný, Tomáš; Pavlović, Nikola; Perge, Peter; Röver, Christian; Schmidt, Georg; Shalganov, Tchavdar; Sritharan, Rajeeva; Svetlosak, Martin; Sallo, Zoltan; Szavits-Nossan, Janko; Traykov, Vassil; Vandenberk, Bert; Velchev, Vasil; Vos, Marc A.; Willich, Stefan N.; Friede, Tim; Willems, Rik; Merkely, Béla; Sticherling, Christian More authors...

Cite this document

Zabel, M., Schlögl, S., Lubinski, A., Svendsen, J. H., Bauer, A., Arbelo, E. ... Sticherling, C. (2019). Present criteria for prophylactic ICD implantation: Insights from the EU-CERT-ICD (Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators in EUrope) project. Journal of electrocardiology, 19., 30415-10417. doi: 10.1016/j.jelectrocard.2019.09.001

Zabel, Markus, et al. "Present criteria for prophylactic ICD implantation: Insights from the EU-CERT-ICD (Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators in EUrope) project." Journal of electrocardiology, vol. 19, 2019, pp. 30415-10417. https://doi.org/10.1016/j.jelectrocard.2019.09.001

Zabel, Markus, Simon Schlögl, Andrzej Lubinski, Jesper Hastrup Svendsen, Axel Bauer, Elena Arbelo, Sandro Brusich, et al. "Present criteria for prophylactic ICD implantation: Insights from the EU-CERT-ICD (Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators in EUrope) project." Journal of electrocardiology 19 (2019): 30415-10417. https://doi.org/10.1016/j.jelectrocard.2019.09.001

Zabel, M., et al. (2019) 'Present criteria for prophylactic ICD implantation: Insights from the EU-CERT-ICD (Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators in EUrope) project', Journal of electrocardiology, 19, pp. 30415-10417. doi: 10.1016/j.jelectrocard.2019.09.001

Zabel M, Schlögl S, Lubinski A, Svendsen JH, Bauer A, Arbelo E, and sur.. Present criteria for prophylactic ICD implantation: Insights from the EU-CERT-ICD (Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators in EUrope) project. Journal of electrocardiology [Internet]. 2019 [cited 2024 November 14];19:30415-10417. doi: 10.1016/j.jelectrocard.2019.09.001

M. Zabel, et al., "Present criteria for prophylactic ICD implantation: Insights from the EU-CERT-ICD (Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators in EUrope) project", Journal of electrocardiology, vol. 19, pp. 30415-10417, 2019. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:905511. [Accessed: 14 November 2024]

Please login to the repository to save this object to your list.
Metadata
Title (english)Present criteria for prophylactic ICD implantation: Insights from the EU-CERT-ICD (Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators in EUrope) project
AuthorMarkus Zabel
AuthorSimon Schlögl
AuthorAndrzej Lubinski
AuthorJesper Hastrup Svendsen
AuthorAxel Bauer
AuthorElena Arbelo
AuthorSandro Brusich
AuthorDavid Conen
AuthorIwona Cygankiewicz
AuthorMichael Dommasch
AuthorPanagiota Flevari
AuthorJan Galuszka
AuthorJim Hansen
AuthorGerd Hasenfuß
AuthorRobert Hatala
AuthorHeikki V. Huikuri
AuthorTuomas Kenttä
AuthorTomasz Kucejko
AuthorHelge Haarmann
AuthorMarkus Harden
AuthorSvetoslav Iovev
AuthorStefan Kääb
AuthorGabriela Kaliska
AuthorAndreas Katsimardos
AuthorJaroslaw D. Kasprzak
AuthorDariusz Qavoq
AuthorLars Lüthje
AuthorMarek Malik
AuthorTomáš Novotný
AuthorNikola Pavlović
AuthorPeter Perge
AuthorChristian Röver
AuthorGeorg Schmidt
AuthorTchavdar Shalganov
AuthorRajeeva Sritharan
AuthorMartin Svetlosak
AuthorZoltan Sallo
AuthorJanko Szavits-Nossan
AuthorVassil Traykov
AuthorBert Vandenberk
AuthorVasil Velchev
AuthorMarc A. Vos
AuthorStefan N. Willich
AuthorTim Friede
AuthorRik Willems
AuthorBéla Merkely
AuthorChristian Sticherling
Author's institutionUniversity of Rijeka
Faculty of Medicine
(Department of Internal Medicine)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Abstract (english)
BACKGROUND: The clinical effectiveness of primary prevention implantable cardioverter defibrillator (ICD) therapy is under debate. It is urgently needed to better identify patients who benefit from prophylactic ICD therapy. The EUropean Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators (EU- CERT-ICD) completed in 2019 will assess this issue. SUMMARY: The EU-CERT-ICD is a prospective investigator-initiated non- randomized, controlled, multicenter observational cohort study done in 44 centers across 15 European countries. A total of 2327 patients with heart failure due to ischemic heart disease or dilated cardiomyopathy indicated for primary prophylactic ICD implantation were recruited between 2014 and 2018 (>1500 patients at first ICD implantation, >750 patients non-randomized non-ICD control group). The primary endpoint was all-cause mortality, and first appropriate shock was co- primary endpoint. At baseline, all patients underwent 12‑lead ECG and Holter-ECG analysis using multiple advanced methods for risk stratification as well as documentation of clinical characteristics and laboratory values. The EU-CERT-ICD data will provide much needed information on the survival benefit of preventive ICD therapy and expand on previous prospective risk stratification studies which showed very good applicability of clinical parameters and advanced risk stratifiers in order to define patient subgroups with above or below average ICD benefit. CONCLUSION: The EU- CERT-ICD study will provide new and current data about effectiveness of primary prophylactic ICD implantation. The study also aims for improved risk stratification and patient selection using clinical risk markers in general, and advanced ECG risk markers in particular.
Keywords (english)
Languageenglish
Publication typeScientific paper - Review paper
Publication statusPublished
Peer reviewPeer review
Publication versionPublished version
Journal titleJournal of electrocardiology
Numberingvol. 19, pp. 30415-10417
p-ISSN0022-0736
DOIhttps://doi.org/10.1016/j.jelectrocard.2019.09.001
URN:NBNurn:nbn:hr:184:905511
Publication2019
Document URLhttp://bib.irb.hr/1031542
Type of resourceText
Access conditionsInstitutional access
Terms of useLicence In copyright icon
Created on2022-03-03 17:39:17